Archive of IoN NEWS

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>

New Yale-UCL collaboration in brain aneurysm genetics

Publication date:

Intracranial aneurysms (swellings of blood vessels in the brain) are the leading cause of subarachnoid haemorrhage, a devastating stroke caused by bleeding around the brain, and a major cause of disability in younger stroke survivors.

The Michael J. Fox Foundation awards grant for Exenatide research

Publication date:

Following encouraging results recently published in the Journal of Clinical Investigation describing the progress of a cohort of patients treated with Exenatide for their Parkinson’s disease (PD), The Michael J. Fox Foundation for Parkinson’s Research has awarded a grant of $1.98 million to Dr. T Foltynie to pursue this avenue of research.

‘Risky’ stroke prevention procedure may be safe in some patients

Publication date:

A major study published in the latest issue of Lancet Neurology, led by researchers at UCL's Institute of Neurology and funded by the Medical Research Council (MRC) and the Stroke Association, has found that stenting in the carotid artery is as safe as carotid artery surgery at reducing stroke risk in some patients.

Institute Professor leads cross-disciplinary study on use of glucose in detecting cancer.

Publication date:

A new technique for detecting cancer by imaging the consumption of sugar with magnetic resonance imaging (MRI) has been unveiled by UCL scientists. The study, led by Professor Xavier Golay, Chair of MR Neurophysics heralds a breakthrough which could provide a safer and simpler alternative to standard radioactive techniques and enable radiologists to image tumours in greater detail.

Irreversible tissue loss seen within 40 days of spinal cord injury

Publication date:

Professor Alan Thompson

The rate and extent of damage to the spinal cord and brain following spinal cord injury have long been a mystery. Now, a joint research effort by UCL, the University of Zurich and University Hospital Balgrist has found evidence that patients already have irreversible tissue loss in the spinal cord within 40 days of injury.

From Bedside to Bench in the Institute’s MRC Centre for Neuromuscular Diseases

Publication date:

'Back translation' provides new insights into mitochondrial biology

Researchers working at the Institute’s MRC Centre for Neuromuscular Diseases have made a potentially important discovery relevant to understanding both mitochondrial biology and human mitochondrial neurological disease. The research is a good example of “back-translation” in which careful research observations in patients can inform knowledge about normal biology.

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>